Could you please clarify the current sentiment and recommendation for VRTX stock among analysts in the financial industry? Are they generally bullish or bearish on the company's future prospects, and what specific rating do they assign to the stock? Understanding the consensus view of analysts can be a valuable tool for investors making decisions about VRTX.
6 answers
Riccardo
Mon Aug 12 2024
Vertex Pharmaceuticals Inc. has been the subject of various analyst ratings in the past three months. The majority of analysts have maintained a 'Hold' rating on the stock, with 118 analysts issuing this opinion.
Ilaria
Mon Aug 12 2024
Additionally, a smaller number of analysts have assigned an 'Underweight' rating to Vertex Pharmaceuticals, totaling 22 analysts. This indicates a slightly bearish outlook on the company's future performance.
Tommaso
Mon Aug 12 2024
On the other hand, only 11 analysts have recommended a 'Sell' rating, suggesting that the majority of analysts do not foresee significant downside potential for the stock in the near term.
Sebastiano
Mon Aug 12 2024
Looking at the consensus opinion, analysts have an 'Overweight' rating on Vertex Pharmaceuticals, indicating a generally positive outlook on the company's prospects.
KpopStarletShineBrightnessStarlight
Sun Aug 11 2024
Notably, the consensus rating has remained 'Overweight' for some time, suggesting that analysts' sentiment towards the stock has been relatively stable.